SMS Pharmaceuticals Shares Price Jump Over 12% After Strong Q2FY26 Performance

Hyderabad, November 10, 2025: Shares of SMS Pharmaceuticals Limited (NSE: SMSPHARMA; BSE:532815) surged 12.05% to ₹328.90 in early trade on Monday, hitting a new 52-week high. The rally came after the company announced strong financial results for the quarter ended September 30, 2025. The rally indicates improved market sentiment around the company.

SMS Pharmaceuticals Limited is a manufacturer of pharmaceutical ingredients (APIs), serving both domestic and international markets. The company has maintained steady growth, supported by a diversified product portfolio and a global client base. Headquartered in Hyderabad, it has been listed since 28 February 2007 and is actively traded on NSE and BSE under the tickers SMSPHARMA and 532815, respectively.

Q2FY26 Financial Highlights (Consolidated)

The company generated ₹24,242.95 lakh in revenue from operations in Q2FY26, marking a 23.2% year-on-year and a 23.7% quarter-on-quarter increase. Total income rose to ₹24,386.34 lakh, a 23.2% YoY growth from Q2FY25. Total expenses also increased, reaching ₹20,982.16 lakh in the second quarter, up 17.6% YoY from Q2FY25.

Despite rising expenses, the company maintained a positive profit before tax, which saw the highest growth. This increase was driven by higher operating income and improved cost efficiencies. Profit Before Tax reached ₹3,404.18 lakh, marking a 74.3% year-on-year increase and a 39.7% quarter-on-quarter rise.

Market Snapshot

As of November 10, 2025, 11:54 am, the share price of SMS Pharmaceuticals Limited was trading at ₹311.55. This is a 7.71% or ₹22.30 rise from its previous close of ₹289.25. The intraday range so far has been between ₹305.00 and ₹328.90. The company has had a positive trading session so far. Its total market capitalisation stood at ₹2,917.73 crore. Further, it had a total traded value and volume of ₹182.62 crore and 57.10 lakh shares, respectively.

SMS Pharmaceuticals Limited is pharmaceutical ingredients (API). The company is catering to domestic and international markets. It has maintained steady growth backed by a diversified product portfolio and a global client base. The company was headquartered in Hyderabad and has been listed since February 28, 2007. It is active on NSE and BSE under the tickers SMSPHARMA and 532815, respectively.

REF: https://nsearchives.nseindia.com/corporate/SMSPHARMA_08112025140419_OutcomeBM_08112025.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations